Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

Griesdale, Donald E. G.; de Souza, Russell J.; van Dam, Rob M.; Heyland, Daren K.; Cook, Deborah J.; Malhotra, Atul; Dhaliwal, Rupinder; Henderson, William R.; Chittock, Dean R.; Finfer, Simon; Talmor, Daniel
April 2009
CMAJ: Canadian Medical Association Journal;4/14/2009, Vol. 180 Issue 8, p821
Academic Journal
Background: Hyperglycemia is associated with increased mortality in critically ill patients. Randomized trials of intensive insulin therapy have reported inconsistent effects on mortality and increased rates of severe hypoglycemia. We conducted a meta-analysis to update the totality of evidence regarding the influence of intensive insulin therapy compared with conventional insulin therapy on mortality and severe hypoglycemia in the intensive care unit (ICU). Methods: We conducted searches of electronic databases, abstracts from scientific conferences and bibliographies of relevant articles. We included published randomized controlled trials conducted in the ICU that directly compared intensive insulin therapy with conventional glucose management and that documented mortality. We included in our meta-analysis the data from the recent NICE-SUGAR (Normoglycemia in Intensive Care Evaluation — Survival Using Glucose Algorithm Regulation) study. Results: We included 26 trials involving a total of 13 567 patients in our meta-analysis. Among the 26 trials that reported mortality, the pooled relative risk (RR) of death with intensive insulin therapy compared with conventional therapy was 0.93 (95% confidence interval [CI] 0.83-1.04). Among the 14 trials that reported hypoglycemia, the pooled RR with intensive insulin therapy was 6.0 (95% CI 4.5-8.0). The ICU setting was a contributing factor, with patients in surgical ICUs appearing to benefit from intensive insulin therapy (RR 0.63, 95% CI 0.44-0.91); patients in the other ICU settings did not (medical ICU: RR 1.0, 95% CI 0.78-1.28; mixed ICU: RR 0.99, 95% CI 0.86-1.12). The different targets of intensive insulin therapy (glucose level ≤ 6.1 mmol/L v. ≤ 8.3 mmol/L) did not influence either mortality or risk of hypoglycemia. Interpretation: Intensive insulin therapy significantly increased the risk of hypoglycemia and conferred no overall mortality benefit among critically ill patients. However, this therapy may be beneficial to patients admitted to a surgical ICU.


Related Articles

  • Blood sugar control in the intensive care unit: time to relook. Rapsang, Amy G.; Shyam, Devajit C. // Southern African Journal of Anaesthesia & Analgesia;2014, Vol. 20 Issue 4, p185 

    The choice of blood sugar control technique in the intensive care unit (ICU) has long been debated. Intensive insulin therapy to achieve normoglycaemia has been shown to reduce mortality, morbidity and the length of ICU stay, but at the same time, frequent glucose monitoring is required, as well...

  • Safe Utilization of Hyperglycemia Management in the ICU. Loh-Trivedi, Mira; Croley, W. Christopher // Current Drug Safety;Jan2010, Vol. 5 Issue 1, p19 

    Critically ill patients admitted to intensive care units (ICUs) often present with multiple medical or surgical problems requiring a high level of care. In addition to a patient's underlying illness, a number of known risk factors can predispose patients to episodes of hyperglycemia as well as...

  • Inhibitory effects of hyperglycemia on neural activity of the vagus in rats. Takahashi, Toku; Matsuda, Kenichi; Kono, Toru; Pappas, Theodore N. // Intensive Care Medicine;Feb2003, Vol. 29 Issue 2, p309 

    Objectives: Although it has been demonstrated that hyperglycemia inhibits gastrointestinal (GI) motility, its inhibitory mechanism remains unclear.Design: Electrophysiological study.Settings: As GI motility is under the influence of the vagus, we studied...

  • Is It Time to Jump off the Intensive Insulin Therapy Bandwagon? Luks, Andrew M. // Critical Care Alert;Jan2009, Vol. 16 Issue 10, p74 

    This single-center, randomized controlled trial demonstrated that intensive insulin therapy targeting blood glucose values of 80-110 mg/dL does not improve mortality, but does increase the incidence of hypoglycemia in a group of critically ill medical and surgical patients.

  • Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Kanji, Salmaan; Singh, Avinder; Tierney, Michael; Meggison, Hilary; McIntyre, Lauralyn; Hebert, Paul C. // Intensive Care Medicine;May2004, Vol. 30 Issue 5, p804 

    Objective: Aggressive glycemic control improves mortality and morbidity in critically ill adults, however implementation of such a strategy can be logistically difficult. This study evaluates the efficiency and safety of a nurse-managed insulin protocol in critically ill...

  • Inpatient Glycemic Management in a Teaching Hospital. Boucai, Laura; Louard, Rita; Zonszein, Joel // Diabetes;Jun2007 Supplement 1, Vol. 56, pA562 

    The article focuses on the findings of a study that characterizes the distribution of capillary blood glucoses (CBG) in all patients including those in intensive care units with diabetes (DM) and stress hyperglycemia (SH). It mentions the association of hyperglycemia with increased morbidity and...

  • The Importance of Strict Blood Glucose Control with Insulin Therapy in the Intensive Care Unit. Van den Heuvel, Ingeborg; Vanhorebeek, Ilse; Van den Berghe, Great // Current Diabetes Reviews;2008, Vol. 4 Issue 3, p227 

    Two randomised controlled trials have shown that maintenance of blood glucose levels below 110 mg/dl with intensive insulin therapy reduces mortality and morbidity of surgical and medical critically ill patients. An absolute reduction in the risk of death of 3-4 % is expected in...

  • Introduction and evaluation of a computerised insulin protocol. Meynaar, Iwan A.; Dawson, Lilian; Tangkau, Peter L.; Salm, Eduard F.; Rijks, Lode // Intensive Care Medicine;Apr2007, Vol. 33 Issue 4, p591 

    Objective: To lower glucose levels in all patients in the intensive care unit (ICU) to the target range of 4.5-7.5 mmol/l using a nurse-driven computerised insulin protocol in combination with bedside glucose measurement.Design: Cohort study.Setting: Mixed...

  • Glycemic Control in the Intensive Care Unit: Why We Should Wait for NICE-SUGAR. Bellomo, Rinaldo; Egi, Moritoki // Mayo Clinic Proceedings;Dec2005, Vol. 80 Issue 12, p1546 

    The article focuses on the importance of glycemic control in critical care medicine. One research claimed that intensive insulin therapy to maintain blood glucose reduces morbidity and mortality among critically ill patients in the surgical intensive care unit. Studies in diabetic patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics